J. Lazarus

发表

Development of a population-specific regression equation to estimate total body water in hemodialysis patients.

G. Chertow, E. Lowrie, J. Lazarus, 1997, Kidney international.

Phase angle predicts survival in hemodialysis patients

G. Chertow, E. Lowrie, D. Jacobs, 1997 .

Predicting Hemodialysis Access Failure with Color Flow Doppler Ultrasound

E. Lowrie, J. Lazarus, N. Lew, 1998, American Journal of Nephrology.

Effect of variability in anemia management on hemoglobin outcomes in ESRD.

J. Lazarus, E. Lacson, N. Ofsthun, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.

A. Collins, C. Solid, M. Krishnan, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose.

E G Lowrie, W. Owen, G. Chertow, 1999, Kidney international.

Survival of patients undergoing chronic hemodialysis and renal transplantation.

E. Lowrie, R. Wilson, J. Lazarus, 1973, The New England journal of medicine.

Balancing Fistula First with Catheters Last.

T. Ikizler, J. Himmelfarb, R. Hakim, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival.

Mark E. Williams, J. Lazarus, E. Lacson, 2006, Kidney international.

CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: The Association between Blood Pressure and Mortality in ESRD—Not Different from the General Population?

Eduardo Lacson, J. Lazarus, E. Lacson, 2007, Seminars in dialysis.

Intensity of Dialysis in Established Acute Renal Failure

G. Chertow, J. Lazarus, 1996 .

Body size, dialysis dose and death risk relationships among hemodialysis patients.

E. Lowrie, J. Lazarus, N. Ofsthun, 2002, Kidney international.

Measurement of dialyzer clearance, dialysis time, and body size: death risk relationships among patients.

E. Lowrie, J. Lazarus, N. Ofsthun, 2004, Kidney international.

The association of race with erythropoietin dose in patients on long-term hemodialysis.

R. Hakim, J. Rogus, J. Lazarus, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Laboratory surrogates of nutritional status after administration of intraperitoneal amino acid-based solutions in ambulatory peritoneal dialysis patients

G. Chertow, E. Lowrie, P. Nordberg, 1995 .

Change in vascular access and hospitalization risk in long-term hemodialysis patients.

R. Hakim, J. Lazarus, E. Lacson, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Change in vascular access and mortality in maintenance hemodialysis patients.

Eduardo Lacson, R. Hakim, J. Lazarus, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

A. Kshirsagar, R. Hakim, N. Key, 2014, Journal of the American Society of Nephrology : JASN.

Dialysis facility ownership and epoetin dosing in hemodialysis patients: a dialysis provider's perspective.

R. Hakim, J. Lazarus, 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

J. Adamson, A. Nissenson, P. Deoreo, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia.

S. Steinberg, E. Lowrie, J. Lazarus, 1975, The Journal of laboratory and clinical medicine.

Anemia in hemodialysis patients: variables affecting this outcome predictor.

W. Owen, E. Lowrie, C. Brugnara, 1997, Journal of the American Society of Nephrology : JASN.

Complications in hemodialysis: an overview.

J. Lazarus, 1980, Kidney international.

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments.

J. Lazarus, N. Ofsthun, M. Teng, 2006, Kidney international.

National Kidney Foundation report on dialyzer reuse

A. Cheung, F. Port, T. Golper, 1997 .

NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

J. Adamson, A. Nissenson, J. Wish, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis.

J. Himmelfarb, R. Hakim, J. Lazarus, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Initiation of Dialysis1

R. Hakim, J. Lazarus, 1995 .

Cost-effectiveness of cancer screening in end-stage renal disease.

W. Owen, G. Chertow, A. Paltiel, 1996, Archives of internal medicine.

National Cooperative rHu Erythropoietin Study in patients with chronic renal failure--an interim report. The National Cooperative rHu Erythropoietin Study Group.

A. Nissenson, N. Levin, J. Lazarus, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis.

T. Ziegler, D. Wilmore, R. Hakim, 1991, Journal of the American Society of Nephrology : JASN.

The association between mental health, physical function, and hemodialysis mortality.

G. Curhan, J. Lazarus, E. Knight, 2003, Kidney international.

Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.

J. Lazarus, J. Merrill, C. Hampers, 1974, Archives of internal medicine.

Intact parathyroid hormone levels in renal insufficiency

P. Aliabadi, M. Sayegh, J. Lazarus, 1995, Calcified Tissue International.

Initiation of dialysis.

R M Hakim, R. Hakim, J. Lazarus, 1994, Advances in nephrology from the Necker Hospital.

Peritoneal dialysis adequacy: a model to assess feasibility with various modalities.

F. Gotch, J. Díaz-Buxó, J. Lazarus, 1999, Kidney international.

Hemodialysis and transplantation in adults with polycystic renal disease.

J. Lazarus, J. Merrill, G. Bailey, 1971, JAMA.

Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients.

L. Szczech, W. Owen, E. Lowrie, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance.

E. Lowrie, J. Díaz-Buxó, J. Lazarus, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs.

T. Ikizler, R. Hakim, J. Lazarus, 2007, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

R. Thadhani, R. Hakim, J. Lazarus, 2009, Journal of the American Society of Nephrology : JASN.

Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients.

J. Egrie, S. Graber, J. Lazarus, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular disease in uremic patients on hemodialysis.

E. Lowrie, J. Lazarus, J. Merrill, 1976, Kidney international. Supplement.

Possible mechanisms of action of plasma exchange in kidney diseases

F. Madoré, J. Lazarus, H. Brady, 2005 .

Dose of hemodialysis and survival: differences by race and sex.

W. Owen, G. Chertow, E. Lowrie, 1998, JAMA.

Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients.

G. Chertow, G. Kaysen, J. Lazarus, 2005, Kidney international.

UNRESOLVED ISSUES IN DIALYSIS: Dialyzer Best Practice: Single Use or Reuse?

J. Lazarus, E. Lacson, 2006, Seminars in dialysis.

Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis

W. Owen, G. Chertow, J. Boyce, 1997 .

The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis.

E G Lowrie, Yan Liu, W. Owen, 1993, The New England journal of medicine.

J. Lazarus, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Conventional Hemodialysis for Acute Renal Failure

W. Owen, G. Chertow, J. Lazarus, 1995 .

Outcomes of older patients receiving chronic dialysis.

W. Owen, G. Chertow, J. Lazarus, 1994, JAMA.

Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose.

E. Lowrie, J. Lazarus, N. Lew, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. The National Kidney Foundation.

W. Keane, R. Hakim, P. Held, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Reprocessing dialysers for multiple uses: recent analysis of death risks for patients.

E. Lowrie, J. Lazarus, N. Ofsthun, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The "right" of passage: surviving the first year of dialysis.

R. Hakim, J. Lazarus, R. Wingard, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Acute renal failure following cardiac operations.

J. Lazarus, R. Chawla, J. Merrill, 1980, The Journal of thoracic and cardiovascular surgery.

Complement activation and hypersensitivity reactions to dialysis membranes.

F. Port, R. Hakim, J. Lazarus, 1984, The New England journal of medicine.

Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes.

R. Hakim, J. Lazarus, E. Lacson, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program.

R. Hakim, J. Lazarus, E. Lacson, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Suspected iron dextran-related adverse drug events in hemodialysis patients.

G. Chertow, J. Lazarus, R. Fletes, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Hemorrhagic pleural effusion in patients undergoing chronic hemodialysis.

S. Steinberg, E. Lowrie, J. Lazarus, 1975, Annals of internal medicine.

What's Wrong With the American Way of ESRD Treatment?

J. Lazarus, 1991 .

Iron overload and mobilization in long-term hemodialysis patients.

R. Hakim, J. Stivelman, J. Lazarus, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Arterial oxygenation during hemodialysis.

N. Feldman, R. Ingram, E. Lowrie, 1977, The New England journal of medicine.

Diffuse pulmonary hemorrhage and rapidly progressive renal failure. An uncommon presentation of Wegener's granulomatosis.

N. Feldman, J. Lazarus, M. Hensley, 1979, The American journal of medicine.

Transplantation without bilateral nephrectomy.

E. Lowrie, J. Lazarus, J. Merrill, 1974, The Journal of urology.

Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease.

W. Owen, B. Walsh, E. Ginsburg, 1996, The Journal of clinical endocrinology and metabolism.

A longitudinal study of bone disease after successful renal transplantation.

T. Strom, J. Kenzora, E. Lowrie, 1978, Nephron.

Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients.

R. Hakim, J. Lazarus, M. Gottlieb, 1985, Kidney international.

The effects of passive CO2 removal on breathing pattern in humans.

J. Weiss, J. Lazarus, T. Rossing, 1986, Respiration; international review of thoracic diseases.

Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients.

R. Hakim, T. Moore, J. Lazarus, 1989, Kidney international.

Acute renal failure in surgical patients. Causes, clinical patterns, and care.

J. Lazarus, N. Tilney, 1983, The Surgical clinics of North America.

Surgery for diverticulitis in renal failure

H. Starnes, J. Lazarus, G. Vineyard, 1985, Diseases of the colon and rectum.

Therapeutic plasma exchange in renal diseases.

F. Madoré, J. Lazarus, H. Brady, 1996, Journal of the American Society of Nephrology : JASN.

Bilateral nephrectomy performed on an emergency basis for life-threatening malignant hypertension.

J. Lazarus, A. Bennett, 1973, Surgery, gynecology & obstetrics.

Bioimpedance norms for the hemodialysis population.

G. Chertow, E. Lowrie, J. Lazarus, 1997, Kidney international.

Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study.

J. Himmelfarb, R. Hakim, J. Lazarus, 1994, Kidney international.

BARORECEPTOR ACTIVITY IN UREMICS Table 3 Linear Regression Slopes before and after Bilateral Nephrectomy Angiotensin slope Amyl nitrite slope Subject

E. Lowrie, J. Lazarus, C. Hampers, 2005 .

MENINGITIS DUE TO THE GROUP B BETA-HEMOLYTIC STREPTOCOCCUS.

W. Marine, J. Lazarus, D. P. Sellers, 1965, The New England journal of medicine.

The effects of varying dialysis regimens on lymphocyte stimulation.

K. S. Hurst, S. Steinberg, T. Strom, 1975, Transactions - American Society for Artificial Internal Organs.

Impact of the Change in CMS Billing Rules for Erythropoietin on Hemoglobin Outcomes in Dialysis Patients

J. Lazarus, N. Ofsthun, 2006, Blood Purification.

Glomerulonephritis in a patient with sarcoidosis. Report of a case and review of the literature.

R. Goldszer, J. Lazarus, E. Galvanek, 1981, Archives of pathology & laboratory medicine.

Successful management of thrombocytopenia, microangiopathic anemia, and acute renal failure by plasmapheresis.

R. Hakim, J. Lazarus, W. H. Churchill, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cancer Screening and Detection in Patients with End-Stage Renal Disease

J. Lazarus, H. Gornik, G. Chertow, 1998, The International journal of artificial organs.

Hemodialysis for acute anuric uric acid nephropathy.

S. Steinberg, E. Lowrie, J. Lazarus, 1975, American journal of diseases of children.

Urgent bilateral nephrectomy for severe hypertension.

J. Lazarus, J. Merrill, C. Hampers, 1972, Annals of internal medicine.

Bilateral nephrectomy in hypertension.

J. Lazarus, C. Hampers, 1975, Annals of internal medicine.

CARDIOPULMONARY BYPASS SURGERY IN CHRONIC HEMP‐DIALYSIS AND TRANSPLANT PATIENTS

J. Collins, E. Lowrie, J. Lazarus, 1977, Transactions - American Society for Artificial Internal Organs.

Antibody response to Engerix‐B® and Recombivax‐HB® hepatitis B vaccination in end‐stage renal disease

J. Lazarus, E. Lacson, N. Ofsthun, 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

Gastrointestinal Complications in Dialysis Patients

D. Mandelbrot, J. Lazarus, 1996 .

Preoperative renal risk stratification.

E. Cook, F. Grover, K. Hammermeister, 1997, Circulation.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

G. Chertow, E. Lowrie, J. Lazarus, 2004, Journal of the American Society of Nephrology : JASN.

Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients.

R. Hakim, J. Stivelman, J. Lazarus, 1989, Kidney international.

Restless legs syndrome in end-stage renal disease.

G. Chertow, J. Winkelman, J. Lazarus, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

R. Thadhani, R. Hakim, J. Lazarus, 2009, Journal of the American Society of Nephrology : JASN.

Prophylaxis of Acute Renal Failure in the Intensive Care Unit

J. Lazarus, 1990 .

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure.

G. Chertow, J. Bonventre, E. Slatopolsky, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Role of bioincompatibility in dialysis morbidity and mortality.

W. Owen, J. Lazarus, J. Lazarus, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.

G. Pinkus, W. Owen, J. Turner, 1998, The American journal of surgical pathology.

Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.

W. Owen, G. Chertow, J. Boyce, 1997, Kidney international.

Biocompatibility of dialysis membranes: effects of chronic complement activation.

D. Fearon, R. Hakim, J. Lazarus, 1984, Kidney international.

Sustained volume expansion and [Na,K]ATPase inhibition in chronic renal failure.

N. Hollenberg, S. Graves, G. Williams, 1994, American journal of hypertension.

Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K]ATPase inhibitor.

N. Hollenberg, S. Graves, G. Williams, 1993, Journal of cardiovascular pharmacology.

Multifrequency bioelectrical impedance estimates the distribution of body water.

G. Chertow, D. Wilmore, K. Cha, 1995, Journal of applied physiology.

The online measurement of hemodialysis dose (Kt): clinical outcome as a function of body surface area.

E. Lowrie, J. Lazarus, N. Ofsthun, 2005, Kidney international.

Vascular Access for Hemodialysis Patency Rates and Results of Revision

R M Hakim, A. Whittemore, R. Hakim, 1985, Annals of surgery.

Quételet's index predicts outcome in cadaveric kidney transplantation

G. Chertow, E. Milford, J. Lazarus, 1996 .

Prognostic stratification in critically ill patients with acute renal failure requiring dialysis.

C. Christiansen, P. Cleary, G. Chertow, 1995, Archives of internal medicine.

Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.

R. Hakim, J. Lazarus, J. Newell, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular Disease in Dialysis Patients

E. Lowrie, J. Lazarus, J. Merrill, 1974 .

Conservative management of uremic pericardial effusions.

J. Collins, J. Lazarus, R. Mee, 1978, The Journal of thoracic and cardiovascular surgery.

Treatment of uremic pericardial effusion.

E. Lowrie, J. Lazarus, J. Merrill, 1975, Proceedings of the Clinical Dialysis and Transplant Forum.

Echocardiographic findings in stable hemodialysis patients.

E. Lowrie, J. Lazarus, J. Merrill, 1976, Proceedings of the Clinical Dialysis and Transplant Forum.

Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients.

E. Lowrie, J. Díaz-Buxó, J. Lazarus, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pericardial effusion associated with minoxidil therapy in dialyzed patients

J. Winchester, J. Lazarus, J. Horton, 1980, The International journal of artificial organs.

Some statistical methods for use in assessing the adequacy of hemodialysis.

E. Lowrie, J. Lazarus, J. Merrill, 1975, Kidney international. Supplement.

Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia.

S. Steinberg, E. Lowrie, J. Lazarus, 1976, Kidney international.

Extracorporeal removal of anti-HLA antibodies in transplant candidates.

J. Himmelfarb, R. Hakim, E. Milford, 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal transplantation--1972.

J. Lazarus, C. Hampers, 1972, Annals of internal medicine.

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients.

Eduardo Lacson, J. Lazarus, E. Lacson, 2003, Kidney international.

Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.

R. Hakim, J. Lazarus, E. Lacson, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.

Mark E. Williams, R. Hakim, J. Lazarus, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Digoxin associates with mortality in ESRD.

R. Hakim, J. Lazarus, Kevin E. Chan, 2010, Journal of the American Society of Nephrology : JASN.

Factitious feculent urine in an adolescent boy.

M. Rogers, J. Lazarus, P. Reich, 1977, JAMA.

Hyperlipidemia after renal transplantation in children.

J. Ingelfinger, E. Lowrie, J. Lazarus, 1976, American journal of diseases of children.

Multicenter clinical validation of an on-line monitor of dialysis adequacy.

A. Nissenson, A. Collins, J. Ebben, 1996, Journal of the American Society of Nephrology : JASN.

Nutrition in hemodialysis patients.

J. Lazarus, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

M. Wolf, E. Lowrie, R. Thadhani, 2003, The New England journal of medicine.

Bilateral nephrectomy in patients with polycystic renal disease.

W. Stewart, J. Lazarus, A. Bennett, 1973, Surgery, gynecology & obstetrics.

Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients.

G. Chertow, E. Lowrie, J. Lazarus, 2000, Kidney international.

Biochemical parameters in chronic renal failure.

R. Hakim, J. Lazarus, J. Lazarus, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Abandoning peracetic acid-based dialyzer reuse is associated with improved survival.

R. Hakim, J. Lazarus, E. Lacson, 2011, Clinical journal of the American Society of Nephrology : CJASN.

CONTROLLED ULTRAFILTRATION (UF) WITH HEMODIALYSIS (HP): ANALYSIS OF COUPLING BETWEEN CONVECTIVE AND DIFFUSIVE MASS TRANSFER IN A NEW HD‐UF SYSTEM

E. Lowrie, J. Lazarus, J. Merrill, 1977, Transactions - American Society for Artificial Internal Organs.

Cardiac arrest and sudden death in dialysis units.

G. Chertow, J. Lazarus, N. Lew, 2001, Kidney international.

Exploring the reverse J-shaped curve between urea reduction ratio and mortality.

W. Owen, G. Chertow, E. Lowrie, 1999, Kidney international.

Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

M. Hernán, M. Wolf, C. Camargo, 2005, Journal of the American Society of Nephrology : JASN.

A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients.

R. Hakim, J. Lazarus, E. Lacson, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Extremes of Glycemic Control (HbA1c) Increase Hospitalization Risk in Diabetic Hemodialysis Patients in the USA

R. Hakim, J. Lazarus, E. Lacson, 2008, American Journal of Nephrology.

Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge.

R. Hakim, J. Lazarus, R. Wingard, 2009, Kidney international.

Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group.

G. Chertow, M. Sayegh, J. Lazarus, 1996, The American journal of medicine.

Vintage, nutritional status, and survival in hemodialysis patients.

K. Johansen, G. Chertow, E. Lowrie, 2000, Kidney international.

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.

E. DeLong, L. Szczech, W. Owen, 2002, JAMA.

The epidemiology of systolic blood pressure and death risk in hemodialysis patients.

Eduardo Lacson, Nathan W Levin, N. Levin, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association between achievement of hemodialysis quality-of-care indicators and quality-of-life scores.

R. Hakim, J. Lazarus, E. Lacson, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluating a new method to judge dialysis treatment using online measurements of ionic clearance.

E. Lowrie, J. Lazarus, N. Ofsthun, 2006, Kidney international.

Toward a Continuous Quality Improvement Paradigm for Hemodialysis Providers with Preliminary Suggestions for Clinical Practice Monitoring and Measurement

W. Owen, J. Lazarus, N. Lew, 2003, Hemodialysis international. International Symposium on Home Hemodialysis.

Association between prevalent care process measures and facility-specific mortality rates.

W. Owen, E. Lowrie, J. Lazarus, 2001, Kidney international.

Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.

J. Lazarus, J. Merrill, C. Hampers, 1973, Archives of internal medicine.

Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.

R. Thadhani, R. Hakim, J. Lazarus, 2010, Clinical journal of the American Society of Nephrology : CJASN.

The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients.

G. Chertow, E. Lowrie, J. Lazarus, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.

T. Strom, E. Milford, R. Kirkman, 1991, Annals of Surgery.

Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group.

R. Lafayette, G. Chertow, M. Sayegh, 1998, Journal of the American Society of Nephrology : JASN.

Baroreceptor Activity in Normotensive and Hypertensive Uremic Patients

E. Lowrie, J. Lazarus, J. Merrill, 1973, Circulation.

Clinical evaluation of postdilution dialysis with a combined ultrafiltration (UF)--hemodialysis (HD) system.

E. Lowrie, J. Lazarus, S. Kumazawa, 1978, Transactions - American Society for Artificial Internal Organs.

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.

A. Levey, T. Greene, V. Buckalew, 1997, Hypertension.

Changing hemodialysis thresholds for optimal survival.

E G Lowrie, L. Szczech, W. Owen, 2001, Kidney international.

Acute renal failure

J. Lazarus, 2004, Intensive Care Medicine.

Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis.

G. Chertow, A. Piccoli, E. Lowrie, 2004, Kidney international.

Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis.

G. Pinkus, W. Owen, C. Benson, 1992, Arthritis and rheumatism.

Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis.

W. Owen, E. Lowrie, J. Lazarus, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The current and future state of the ESRD program: a provider roundtable.

A. Nissenson, S. Lindenfeld, S. Bander, 2000, Seminars in nephrology.

Comparison of hemodialysis blood access flow rates using online measurement of conductivity dialysance and ultrasound dilution.

Eduardo Lacson, F. Gotch, J. Lazarus, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Nutrition and the dialysis prescription.

G. Chertow, J. Lazarus, A. Bullard, 1996, American Journal of Nephrology.

Femoral Triangle Sepsis in Dialysis Patients: Frequency, Management, and Outcome

D. C. Knight, J. Lazarus, A. Morgan, 1980, Annals of surgery.

Surgical care of the patient with renal failure

J. Lazarus, N. Tilney, 1982 .

The "right" of passage: surviving the first year of dialysis.

R. Hakim, J. Lazarus, R. Wingard, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Vascular access in hemodialysis.

J. Lazarus, A. Morgan, 1974, AORN journal.

Cardiovascular instability during hemodialysis.

M. Weiner, L. Henderson, C. Kjellstrand, 1982, Transactions - American Society for Artificial Internal Organs.

Long-term results of cyclosporine treatment in renal transplantation.

T. Strom, E. Milford, R. Kirkman, 1986, Transplantation proceedings.